FDMT vs TT · rev $37.0K vs P/E 36, rev $21.32B
4D Molecular Therapeutics Inc (FDMT) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
FDMT currently screens at market cap $518.1M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the FDMT and TT stock pages for the full models.
Not investment advice.